Causal insights from failure. What pharmacovigilance can teach us about causality

Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?

Research / 17 November 2020

Pharmacogenomics group aims to refine patient safety options

Better understanding of genetic variation – between individuals and subpopulations – can inform more refined choices of drugs and doses. A new ISoP group is set to drive progress.

Research / 01 July 2020

Hello researcher, what are you reading? Qun-Ying Yue

Catch up with our research team and find out what's keeping a researcher intrigued right now.

Research / 10 April 2020

EHDEN consortium seeking better value from data

Despite great progress, real-world data that could be better exploited to research and improve healthcare systems, services and treatments, for the benefit of patients.

Research / 03 April 2020

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more